Molderings, G. J. http://orcid.org/0000-0002-9005-2749
Dumoulin, F. L.
Homann, J.
Sido, B.
Textor, J.
Mücke, M.
Qagish, G. J.
Barion, R.
Raithel, M.
Klingmüller, D.
Schäfer, V. S.
Hertfelder, H. J.
Berdel, D.
Tridente, G.
Weinstock, L. B.
Afrin, L. B.
Funding for this research was provided by:
Förderclub Mastzellforschung e.V.
Article History
Received: 31 March 2020
Accepted: 24 April 2020
First Online: 6 May 2020
Compliance with ethical standards
:
: Gerhard J. Molderings is chief medical officer of the company MC Sciences developing drugs for therapy of mast cell diseases. All other authors have stated that they have no conflicts of interest.
: Publication was supported by the Förderclub Mastzellforschung e.V. Informed consents for publication have been obtained from our patients.